Announcements Trials

Browse Landscape

Phase

Status

Terminated 2 Withdrawn 1 Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 17 Esophageal Neoplasms 9 Glioblastoma 8 Squamous Cell Carcinoma of Head and Neck 7 Rectal Neoplasms 7 Oropharyngeal Neoplasms 7 Breast Neoplasms 7 Mouth Neoplasms 6 Glioma 6 Triple Negative Breast Neoplasms 4 Lung Neoplasms 4 Laryngeal Neoplasms 4 Head and Neck Neoplasms 4 Brain Neoplasms 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Stomach Neoplasms 3 Sarcoma 3 Pancreatic Neoplasms 3 Multiple Myeloma 3 Neuroblastoma 2 Neoplasms 2 Nasopharyngeal Carcinoma 2 Melanoma 2 Medulloblastoma 2 Hypopharyngeal Neoplasms 2 Ganglioneuroblastoma 2 Esophageal Squamous Cell Carcinoma 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2

Interventions

Cyclophosphamide 21 venetoclax 18 pembrolizumab 16 Dexamethasone 16 fludarabine 14 Cytarabine 13 Gemcitabine 9 pomalidomide 8 Rituximab 8 Carboplatin 8 Azacitidine 8 glofitamab 7 fludarabine phosphate 7 Lenalidomide 7 Immunotherapy, Adoptive 7 selinexor 6 Paclitaxel 6 Injections 6 Granulocyte Colony-Stimulating Factor 6 Cisplatin 6 daratumumab 5 Temozolomide 5 Oxaliplatin 5 Bevacizumab 5 zanubrutinib 4 ruxolitinib 4 Surgical Procedures, Operative 4 Nivolumab 4 Drug Therapy 4 Decitabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Recurrence × Radiation × Clear all

NCT03970447 2026-05-15

GBM AGILE

Global Coalition for Adaptive Research

Phase 2/3 Recruiting

Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡